Bezafibrate Improves GLOBE and UK‐PBC Scores and Long‐Term Outcomes in Patients With Primary Biliary CholangitisAkira Honda, Atsushi Tanaka, Tetsuji Kaneko et al.|Hepatology|2019Cited by 119
Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control studyKosuke Matsumoto, Atsushi Tanaka, Satoko Ohfuji et al.|Journal of Gastroenterology|2021Cited by 34
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinibIlario Giovanni Rapposelli, Margherita Rimini, Toshifumi Tada et al.|Liver International|2021Cited by 25
A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitisMinami Yagi, Kosuke Matsumoto, Atsumasa Komori et al.|Liver International|2020Cited by 21
Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinomaIlario Giovanni Rapposelli, Andrea Casadei‐Gardini, Shigeo Shimose et al.|ESMO Open|2021Cited by 20